Understanding Anti-HBs Titre: Normal vs Optimal Ranges

Also known as: hepatitis b surface antibody, anti-hbs, hbsab, hepatitis b antibody to surface antigen

Immune FunctionUnit: mIU/mL

?What is Anti-HBs Titre?

Anti-HBs (Hepatitis B surface antibody) is produced by the immune system in response to hepatitis B vaccination or natural infection with the hepatitis B virus. A detectable anti-HBs titre indicates immunity to hepatitis B infection. This marker is used to confirm successful vaccination response and to assess long-term protective immunity.

!Why It Matters

Anti-HBs titre is a key indicator of protection against hepatitis B, a virus that can cause acute and chronic liver disease. A titre below 10 mIU/mL may suggest inadequate immunity and could indicate the need for vaccination or a booster dose. Monitoring this marker helps ensure sustained immunity, particularly in healthcare workers, frequent travellers, and immunocompromised individuals.

Reference Ranges

Range TypeMinMaxUnitNote
Lab Normal10mIU/mLStandard lab reference range
Optimal100mIU/mLEvidence-based optimal range for health
Longevity Target100mIU/mLPer longevity medicine research (Attia et al.)

Lab normal ranges may vary between laboratories. Optimal and longevity targets are based on research literature and should be interpreted with your physician.

Symptoms of Imbalance

  • No symptoms typically associated with low anti-HBs; assessment is preventive
  • History of hepatitis B exposure or infection
  • Recent hepatitis B vaccination
  • Occupational exposure risk (healthcare workers)
  • Immunocompromised status

How to Improve Your Levels

  • 1Complete the primary hepatitis B vaccination series if not previously vaccinated
  • 2Receive a booster dose if anti-HBs titre falls below protective levels
  • 3Ensure adequate time (4–6 weeks) between booster dose and retesting for titre assessment
  • 4Maintain overall immune health through balanced nutrition, adequate sleep, and regular exercise
  • 5Discuss with your doctor if immunocompromised, as response to vaccination may be reduced
  • 6Consider revaccination if titre remains low after standard boosters

When to Test

Test anti-HBs titre 1–2 months after completing the primary hepatitis B vaccination series to confirm response. Retest every 5–10 years or if titre falls below protective levels. Test sooner if immunocompromised or after significant potential exposure.

Related Biomarkers

Track your Anti-HBs Titre with ByoMap

Upload your blood report and get personalized Anti-HBs Titre ranges based on your age, sex, and ancestry — free.

Try Free — Upload Your Report